ADAPY · Adaptimmune Therapeutics PLC
$0.03
+0.01 (+22.81%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Aug 13, 2025
Market Cap
$44.53M
Shares
1.59B
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $73
Total Shares: 3,661
Institutional Ownership Trend
25 quarters
Holder Concentration
Across 1 13F filers · Δ vs Dec 31, 2025Top Holder
100.0%
+51.8 pts
Top 5
100.0%
+2.1 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated+6,542
Quarterly Activity
vs Dec 31, 2025
New
0
Increased
0
Decreased
0
Sold Out
10
Unchanged
1
Holder count:
-10
Institutional value:
-99.8%
Shares held:
-99.8%
Top New Positions
vs Dec 31, 2025No new positions this quarter.
Top Sold-Out Positions
vs Dec 31, 2025| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mid Empirical Finance, LLC | 800,000 | $20,800 | |
| Large Rathbones Group PLC | 432,818 | $11,253 | |
| Mid XTX Topco Ltd | 353,836 | $9,199 | |
| Small JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 20,000 | $520 | |
| Mid SIMPLEX TRADING, LLC | 18,610 | $483 |
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Mega RHUMBLINE ADVISERS | $73 | 100.00% | 3,661 | Shares | 2026-05-12 |